About Hemen Life Sciences
Hemen Life Sciences offers products and services including APIs and Formulations.
- SectorsHealthcare
- Email••••••••
- Legal Name Hemen Life Sciences Pvt Ltd
- Date of Incorporation 16 Nov, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹3.22 Cr
FY 2025 · -1% YoY
- Net Loss-₹49.1 Lakh
FY 2025 · -15% margin
- EBITDA-₹47.9 Lakh
FY 2025 · -15% margin
Associated legal entities of Hemen Life Sciences
Hemen Life Sciences operates through Hemen Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hemen Life Sciences Private Limited CIN U74999MH2017PTC301875 | Active | 16 Nov 2017 | Mumbai, Maharashtra | ₹3.2 Cr | – | 3 | View details |
Products & Services of Hemen Life Sciences
Hemen Life Sciences offers a comprehensive portfolio of products and services, including APIs and Formulations.
Active Pharmaceutical Ingredients are supplied and exported to various pharmaceutical companies.
Finished formulations such as tablets and capsules are provided through contract manufacturing.
Board of directors of Hemen Life Sciences Private Limited (Hemen Life Sciences)
Hemen Life Sciences Private Limited is the primary company behind Hemen Life Sciences. The board of Hemen Life Sciences Private Limited currently have 3 directors; the longest-serving is Satheesh Gopinath Nair, appointed in 2017. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satheesh Gopinath Nair DIN 07978646 | Director | 16 Nov 2017 | 8 yrs 10 mo | Hemen Life Sciences Private Limited |
| Rajeev Pulparambil Raveendran DIN 07068749 | Additional Director | 01 Feb 2019 | 7 yrs 8 mo | Hemen Life Sciences Private Limited |
| Sandeep Shenoy Rohidas DIN 07231259 | Additional Director | 15 Sep 2025 | 1 yr | Hemen Life Sciences Private Limited |
Financials of Hemen Life Sciences
Figures of Hemen Life Sciences Private Limited, the primary company behind Hemen Life Sciences, for FY 2025. Revenue was ₹3.22 Cr (-1% year on year). Net loss was -₹49.1 Lakh (-15% margin). EBITDA was -₹47.9 Lakh (-15% margin). Revenue has grown at a compounded annual rate of -32% over three years and -35% over five years.
- ₹3.22 CrRevenue · FY 2025 · -1% YoY
- -₹49.1 LakhNet loss · -15% margin
- -₹47.9 LakhEBITDA · -15% margin
- ₹1 LakhPaid-up capital
- -32%Revenue CAGR, 3 years
- -35%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hemen Life Sciences Private Limited are on its company page.
Detailed financial statements for Hemen Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Hemen Life Sciences
10 companies that operate in the same segment as Hemen Life Sciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hemen Life Sciences
The primary company behind Hemen Life Sciences, Hemen Life Sciences Private Limited, reported revenue of ₹3.22 Cr for FY 2025, down 1% year on year.
Hemen Life Sciences is recognized as a supplier of pharmaceutical and healthcare products to customers globally. It is involved in exporting intermediates, APIs, formulations, and surgicals to regions such as Africa, Middle East, Far East, and Latin America. Contract manufacturing services are provided through ISO 9001:2000 and GMP certified facilities. Quality is monitored at every stage, from raw material procurement to final delivery, ensuring compliance with international standards. Formulation development for solid and liquid products is also undertaken.
Hemen Life Sciences offers APIs and Formulations.
Hemen Life Sciences operates through Hemen Life Sciences Private Limited.
The legal entities of Hemen Life Sciences currently have 3 directors, including Satheesh Gopinath Nair, Sandeep Shenoy Rohidas, Rajeev Pulparambil Raveendran.